Nonalcoholic fatty liver illness (NAFLD) outcomes in the accumulation of fats in the liver and can progress as an inflammatory dysfunction with appreciable vascular endothelial dysfunction referred to as nonalcoholic steatohepatitis (NASH). Inflammatory alerts can set off the expression of vascular cell adhesion molecule 1 (VCAM-1) on endothelial cells. VCAM-1 is a floor protein that induces adherence and extravasation of monocytes to blood vessels. In this problem of the JCI, Furuta et al. report on their sequencing of RNA transcripts from the livers of mice fed a NASH-inducing eating regimen. VCAM-1 was upregulated in the entire liver in addition to liver sinusoidal endothelial cells (LSECs).
When the researchers incubated LSECs with palmitate, a poisonous lipid, VCAM-1 was upregulated. Notably, inhibiting VCAM-1 in the NASH mannequin decreased VCAM-1 expression, lessened infiltrating macrophages, and mitigated fibrosis. This research connects steatosis to endothelial dysfunction and irritation and means that concentrating on VCAM-1 might handle fibrosis in sufferers with NASH.
We acquired responses from 169 of 540 surveyed U.S. hospitals (response charge: 31.3%). Almost all hospitals canceled or postponed elective surgical procedures (96.7%) and non-surgical procedures (94.8%). Few hospitals created new medical models in areas not sometimes devoted to well being care (12.9%), and virtually none adopted triage protocols (5.6%) or protocols to attach a number of sufferers to a single ventilator (4.8%). Actions to extend or protect intensive care unit (ICU) employees, together with use of ICU telemedicine, have been extremely variable, with none single dominant technique.
Hospitals experiencing increased incidence of COVID-19 didn’t constantly take completely different actions in comparison with hospitals dealing with decrease incidence.Responses of hospitals to the mass want for essential care providers because of the COVID-19 pandemic have been extremely variable. Most hospitals canceled procedures to protect ICU capability and scaled up ICU capability utilizing present medical house and staffing. Future work linking hospital response to affected person outcomes can inform planning for extra surges of this pandemic or different occasions in the future.
Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum
Tourette syndrome (TS) is commonly discovered comorbid with different neurodevelopmental problems throughout the impulsivity-compulsivity spectrum, with attention-deficit/hyperactivity dysfunction (ADHD), autism spectrum dysfunction (ASD), and obsessive-compulsive dysfunction (OCD) as most prevalent. This factors to the chance of a standard etiological thread alongside an impulsivity-compulsivity continuum. Investigating the shared genetic foundation throughout TS, ADHD, ASD, and OCD, we undertook an analysis of cross-disorder genetic structure and systematic meta-analysis, integrating abstract statistics from the newest genome-wide affiliation research (93,294 people, 6,788,510 markers).
As beforehand recognized, a standard unifying issue connects TS, ADHD, and ASD, whereas TS and OCD present the highest genetic correlation in pairwise testing amongst these problems. Thanks to a extra homogeneous set of problems and a focused method that’s guided by genetic correlations, we have been capable of determine a number of novel hits and areas that appear to play a pleiotropic position for the particular problems analyzed right here and couldn’t be recognized by earlier research. In the TS-ADHD-ASD genome-wide affiliation research single nucleotide polymorphism-based and gene-based meta-analysis, we uncovered 13 genome-wide vital areas that host single nucleotide
polymorphisms with a excessive posterior chance for affiliation with all three studied problems (m-value > 0.9), 11 of which weren’t recognized in earlier cross-disorder evaluation. In distinction, we additionally recognized two extra pleiotropic areas in the TS-OCD meta-analysis. Through conditional evaluation, we highlighted genes and genetic areas that play a particular position in a TS-ADHD-ASD genetic issue versus TS-OCD. Cross-disorder tissue specificity evaluation implicated the hypothalamus-pituitary-adrenal gland axis in TS-ADHD-ASD.
Mitochondrial related ER membrane (MAM) compartment and its dysregulation in Amyotrophic lateral sclerosis (ALS)
The endoplasmic reticulum (ER) and mitochondria join at a number of contact websites to kind a novel mobile compartment, termed the ‘mitochondria-associated ER membranes’ (MAMs). MAMs are hubs for signalling pathways that regulate mobile homeostasis and survival, metabolism, and sensitivity to apoptosis. MAMs are due to this fact concerned in important mobile capabilities, however they’re dysregulated in a number of human illnesses. Whilst MAM dysfunction is more and more implicated in the pathogenesis of neurodegenerative illnesses, its position in amyotrophic lateral sclerosis (ALS) is poorly understood.
However, in ALS each ER and mitochondrial dysfunction are nicely documented pathophysiological occasions. Moreover, alterations to lipid metabolism in neurons regulate processes linked to neurodegenerative illnesses, and a hyperlink between lipid metabolism dysfunction and ALS has additionally been proposed. In this overview we talk about the structural and useful relevance of MAMs in ALS and how concentrating on MAM may very well be therapeutically useful in this dysfunction this disoefdisorder. Intracellular adaptor proteins are indispensable for the transduction of receptor-derived alerts, as they recruit and join important downstream effectors.
The SLy/SASH1-adaptor household includes three extremely homologous proteins, all of them sharing conserved structural motifs. The preliminary characterization of the first member SLy1/SASH3 in 2001 was quickly adopted by identification of SLy2/HACS1 and SASH1/SLy3 (SAM and SH3 area containing 1). Based on their pronounced sequence similarity, they have been subsequently categorized as one household of intracellular scaffold proteins. Despite their apparent homology, the three SLy/SASH1-members essentially differ with regard to their expression and operate in intracellular signaling.
Infectious Bursal Disease Virus (VP3) Antibody |
|
GWB-5BBB8A |
GenWay Biotech |
1 mg |
Ask for price |
Infectious Bursal Disease Virus (VP2) Antibody |
|
GWB-7664C4 |
GenWay Biotech |
1 mg |
Ask for price |
Infectious Bursal Disease Virus (VP2) Antibody |
|
GWB-100245 |
GenWay Biotech |
1 mg |
Ask for price |
|
|
Infectious Bursal Disease Virus (VP3) Antibody |
|
GWB-17F01B |
GenWay Biotech |
1 mg |
Ask for price |
|
|
Infectious bursal disease virus PCR kit |
|
PCR-V052-48R |
Bioingentech |
50T |
EUR 987.6 |
Infectious bursal disease virus PCR kit |
|
PCR-V052-96R |
Bioingentech |
100T |
EUR 1335.6 |
Infectious Bursal Disease Virus Antibody (IBDV-Ab) Elisa Kit |
|
EK782068 |
AFG Bioscience LLC |
96 Wells |
EUR 0.99 |
Infectious bursal disease virus RT PCR kit |
|
RTq-V052-100R |
Bioingentech |
100T |
EUR 1573.2 |
Infectious bursal disease virus RT PCR kit |
|
RTq-V052-150R |
Bioingentech |
150T |
EUR 2144.4 |
Infectious bursal disease virus RT PCR kit |
|
RTq-V052-50R |
Bioingentech |
50T |
EUR 1155.6 |
Infectious Bursal Disease Virus (IBDV, VP3) (PE) |
|
MBS6129379-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus (IBDV, VP3) (PE) |
|
MBS6129379-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus VP2 (IBDV) (PE) |
|
MBS6129380-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus VP2 (IBDV) (PE) |
|
MBS6129380-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus (IBDV, VP3) (AP) |
|
MBS6126283-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus (IBDV, VP3) (AP) |
|
MBS6126283-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus VP2 (IBDV) (AP) |
|
MBS6126284-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus VP2 (IBDV) (AP) |
|
MBS6126284-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Recombinant Infectious Bursal Disease Virus VP2 |
|
DAG-WT652 |
Creative Diagnostics |
1 mg |
EUR 895 |
|
|
|
Description: Recombinant |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) |
|
MBS633520-1mg |
MyBiosource |
1mg |
EUR 1080 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) |
|
MBS633520-5x1mg |
MyBiosource |
5x1mg |
EUR 4705 |
Infectious Bursal Disease Virus (IBDV, VP3) (HRP) |
|
MBS6128759-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus (IBDV, VP3) (HRP) |
|
MBS6128759-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus VP2 (IBDV) (HRP) |
|
MBS6128760-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus VP2 (IBDV) (HRP) |
|
MBS6128760-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus (IBDV, VP3) (APC) |
|
MBS6126903-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus (IBDV, VP3) (APC) |
|
MBS6126903-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus VP2 (IBDV) (APC) |
|
MBS6126904-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus VP2 (IBDV) (APC) |
|
MBS6126904-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus (IBDV, VP3) (FITC) |
|
MBS6128138-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus (IBDV, VP3) (FITC) |
|
MBS6128138-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus VP2 (IBDV) (FITC) |
|
MBS6128139-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus VP2 (IBDV) (FITC) |
|
MBS6128139-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus (IBDV) ELISA Kit |
|
abx050271-1mg |
Abbexa |
1 mg |
EUR 493.75 |
Infectious Bursal Disease Virus (IBDV) ELISA Kit |
|
abx050271-5mg |
Abbexa |
5 mg |
Ask for price |
Infectious Bursal Disease Virus (IBDV, VP3) (Biotin) |
|
MBS6127524-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus (IBDV, VP3) (Biotin) |
|
MBS6127524-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus VP2 (IBDV) (Biotin) |
|
MBS6127525-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus VP2 (IBDV) (Biotin) |
|
MBS6127525-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Chicken Infectious Bursal Disease Virus Antibody,IBDV Ab ELISA KIT |
|
JOT-EKD0024Ch |
Jotbody |
96 wells |
EUR 398.4 |
|
Description: Chicken |
Chicken Infectious Bursal Disease Virus Antibody, IBDV Ab ELISA Kit |
|
MBS1610263-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4470 |
Chicken Infectious Bursal Disease Virus Antibody, IBDV Ab ELISA Kit |
|
MBS1610263-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2270 |
Chicken Infectious Bursal Disease Virus Antibody, IBDV Ab ELISA Kit |
|
MBS1610263-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 540 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (PE) |
|
MBS6129381-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (PE) |
|
MBS6129381-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (PE) |
|
MBS6129382-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (PE) |
|
MBS6129382-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (AP) |
|
MBS6126285-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (AP) |
|
MBS6126285-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (AP) |
|
MBS6126286-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (AP) |
|
MBS6126286-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (HRP) |
|
MBS6128761-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (HRP) |
|
MBS6128761-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (HRP) |
|
MBS6128762-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (HRP) |
|
MBS6128762-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (APC) |
|
MBS6126905-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (APC) |
|
MBS6126905-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (APC) |
|
MBS6126906-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (APC) |
|
MBS6126906-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (FITC) |
|
MBS6128140-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (FITC) |
|
MBS6128140-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (FITC) |
|
MBS6128141-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (FITC) |
|
MBS6128141-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Infectious bursal disease virus One-Step PCR kit |
|
Oneq-V052-100R |
Bioingentech |
100T |
EUR 1932 |
Infectious bursal disease virus One-Step PCR kit |
|
Oneq-V052-150R |
Bioingentech |
150T |
EUR 2646 |
Infectious bursal disease virus One-Step PCR kit |
|
Oneq-V052-50R |
Bioingentech |
50T |
EUR 1410 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (Biotin) |
|
MBS6127526-01mL |
MyBiosource |
0.1(mL |
EUR 1310 |
Infectious Bursal Disease Virus, VP2 (IBD, IBDV) (Biotin) |
|
MBS6127526-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5740 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (Biotin) |
|
MBS6127527-01mL |
MyBiosource |
0.1(mL |
EUR 1285 |
Infectious Bursal Disease Virus, VP3 (IBD, IBDV) (Biotin) |
|
MBS6127527-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5640 |
Chicken Infectious Bursal Disease Virus (IBDV) ELISA Kit |
|
abx050271-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
Chicken Infectious Bursal Disease virus(IBDV) ELISA Kit |
|
NSL1557Ch |
Sunlong |
each |
Ask for price |
Infectious bursal disease virus Pathotyping RT PCR kit |
|
RTq-V589-100R |
Bioingentech |
100T |
EUR 1573.2 |
Infectious bursal disease virus Pathotyping RT PCR kit |
|
RTq-V589-150R |
Bioingentech |
150T |
EUR 2144.4 |
Infectious bursal disease virus Pathotyping RT PCR kit |
|
RTq-V589-50R |
Bioingentech |
50T |
EUR 1155.6 |
Chicken Infectious Bursal Disease virus(IBDV) ELISA Kit |
|
SL0123Ch |
Sunlong |
- |
EUR 528 |
|
|
Chicken Infectious Bursal Disease Virus Antigen Rapid Test Kit |
|
abx092114-100l |
Abbexa |
100 µl |
EUR 300 |
Chicken Infectious Bursal Disease Virus Antigen Rapid Test Kit |
|
abx092114-1ml |
Abbexa |
1 ml |
Ask for price |
Chicken Infectious Bursal Disease Virus Antigen Rapid Test Kit |
|
abx092114-200l |
Abbexa |
200 µl |
Ask for price |
Avian infectious bursal disease virus Structural polyprotein |
|
1-CSB-RP182094V |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
|
|
Description: Recombinant Avian infectious bursal disease virus Structural polyprotein,partial expressed in E.coli |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS1265131-002mg |
MyBiosource |
0.02mg |
EUR 375 |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS1265131-01mg |
MyBiosource |
0.1mg |
EUR 635 |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS1265131-1mg |
MyBiosource |
1mg |
EUR 1925 |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS1265131-5x1mg |
MyBiosource |
5x1mg |
EUR 8405 |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS9422129-002mg |
MyBiosource |
0.02mg |
EUR 460 |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS9422129-01mg |
MyBiosource |
0.1mg |
EUR 795 |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS9422129-1mg |
MyBiosource |
1mg |
EUR 2525 |
Recombinant Avian infectious bursal disease virus Polyprotein |
|
MBS9422129-5x1mg |
MyBiosource |
5x1mg |
EUR 11205 |
genesig Easy kit for Infectious Bursal Disease Virus (IBDV) |
|
Z-Path-IBDV-EASY |
Novacyt Group |
50 tests |
EUR 410 |
|
Description: IBDV |
Infectious bursal disease virus Pathotyping One-Step PCR kit |
|
Oneq-V589-100R |
Bioingentech |
100T |
EUR 1932 |
Infectious bursal disease virus Pathotyping One-Step PCR kit |
|
Oneq-V589-150R |
Bioingentech |
150T |
EUR 2646 |
Infectious bursal disease virus Pathotyping One-Step PCR kit |
|
Oneq-V589-50R |
Bioingentech |
50T |
EUR 1410 |
Chicken Infectious bursal disease virus VP2 antibody (IBDV-VP2-Ab) ELISA Kit |
|
AE64466CH-48T |
Abebio |
48T |
EUR 360 |
|
|
|
Description: Chicken (Gallus) |
Chicken Infectious bursal disease virus VP2 antibody (IBDV-VP2-Ab) ELISA Kit |
|
AE64466CH-48Tests |
Abebio |
48 Tests |
EUR 360 |
|
|
|
Description: Chicken (Gallus) |
Chicken Infectious bursal disease virus VP2 antibody (IBDV-VP2-Ab) ELISA Kit |
|
AE64466CH-96T |
Abebio |
96T |
EUR 680 |
|
|
|
Description: Chicken (Gallus) |
Chicken Infectious bursal disease virus VP2 antibody (IBDV-VP2-Ab) ELISA Kit |
|
AE64466CH-96Tests |
Abebio |
96 Tests |
EUR 680 |
|
|
|
Description: Chicken (Gallus) |
Chicken Infectious bursal disease virus VP2 antibody, IBDV-VP2-Ab ELISA KIT |
|
JOT-EKD0035Ch |
Jotbody |
96 wells |
EUR 398.4 |
|
Description: Chicken |
Chicken Infectious bursal disease virus VP2 antibody (IBDV-VP2-Ab) ELISA Kit |
|
EK12345 |
SAB |
96Т |
EUR 799 |
|
|
Chicken Infectious bursal disease virus VP2 antibody, IBDV-VP2-Ab ELISA Kit |
|
MBS1610327-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4470 |
Chicken Infectious bursal disease virus VP2 antibody, IBDV-VP2-Ab ELISA Kit |
|
MBS1610327-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2270 |
Chicken Infectious bursal disease virus VP2 antibody, IBDV-VP2-Ab ELISA Kit |
|
MBS1610327-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 540 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1328903-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1328903-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1328903-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1328903-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1328903-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1235 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1021480-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1021480-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1021480-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1021480-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5) |
|
MBS1021480-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1235 |
Infectious Bursal Disease Virus (IBDV) Probe-based RT-qPCR Kit |
|
MK1F14 |
BioVenic |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 Tests
- 48 Test
- 50 Tests
|
Recombinant Avian infectious bursal disease virus Structural polyprotein |
|
MBS1003928-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1840 |
Recombinant Avian infectious bursal disease virus Structural polyprotein |
|
MBS1003928-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1640 |
Recombinant Avian infectious bursal disease virus Structural polyprotein |
|
MBS1003928-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1600 |
Recombinant Avian infectious bursal disease virus Structural polyprotein |
|
MBS1003928-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1985 |
Recombinant Avian infectious bursal disease virus Structural polyprotein |
|
MBS1003928-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1885 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1245189-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1245189-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1245189-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1245189-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1245189-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1235 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1110433-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1110433-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1110433-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1110433-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1110433-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1235 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1248547-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1248547-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1248547-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1248547-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1248547-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1235 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1013224-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1013224-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1013224-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 915 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1013224-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1140 |
Recombinant Avian infectious bursal disease virus Protein VP5 (VP5), partial |
|
MBS1013224-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1235 |
Recombinant Avian infectious bursal disease virus Structural polyprotein,partial |
|
AP72379 |
SAB |
1mg |
EUR 2826 |
|
|
Recombinant Avian infectious bursal disease virus Structural polyprotein, partial |
|
CSB-RP182094V |
Cusabio |
5424 mg |
Ask for price |
Recombinant Avian infectious bursal disease virus Structural polyprotein, partial |
|
CSB-RP182094V-20ug |
Cusabio |
20ug |
Ask for price |
|
|
|
Description: 723-1012aa |
Recombinant Avian infectious bursal disease virus Structural polyprotein, partial |
|
MBS1130062-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Avian infectious bursal disease virus Structural polyprotein, partial |
|
MBS1154881-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
On the opposite, rising proof clearly demonstrates an necessary position of all three proteins in human well being and illness. In this overview, we systematically summarize what is understood about the SLy/SASH1-adaptors in the discipline of molecular cell biology and immunology. To this finish, we recapitulate present analysis about SLy1/SASH3, SLy2/HACS1, and SASH1/SLy3, with an emphasis on their similarities and variations.